(21174) Relative bioavailability study to investigate the pharmacokinetics of a single oral dose of asundexian administered as 50 mg pediatric formulation in comparison to 50 mg tablet (adult formulation) in fasted state and to investigate the effect of a high-fat, high-calorie meal on the 50 mg pediatric formulation in healthy adult participants
Harmful blood clots can block blood vessels and cause severe medical issues such as strokes. Asundexian is an experimental medicine being developed to stop these clots from forming. While adult tablets already exist, scientists have developed a new granule form that may be much easier for children or people who struggle to swallow pills. Before giving these granules to children, researchers must understand exactly how the human body takes them in. This Phase 1 study asks healthy adult volunteers to take a single dose of the granules and compare it to the standard tablet. Volunteers will also take the granules after a rich breakfast to see if food changes how the medicine is absorbed. By taking regular blood samples, the study team can confirm whether the granules are safe and work as expected.
At a glance
What is this study about?
Blood clots are clumps of blood that form to stop bleeding when you have a cut. Sometimes, however, dangerous clots form inside blood vessels and can lead to serious problems such as strokes or heart attacks. Asundexian is a new type of blood-thinning medicine currently being researched to help prevent these dangerous clots.
At the moment, asundexian is usually given as a standard tablet. Because swallowing large tablets can be difficult or distressing for young children, researchers have created an alternative version made of tiny granules. These granules could eventually be mixed with food or drinks to make taking the medicine much simpler for younger patients.
Before this new version can be tested in children, doctors must check how the body processes it in healthy adults. This study measures how much of the medicine gets into the bloodstream and how quickly it leaves. The team also wants to see if eating a hearty, high-fat meal changes the way the granules are absorbed, helping doctors give clear instructions to future patients on whether to take it with food.
Key takeaways
- Tests a new child-friendly granule form of the blood-thinner asundexian.
- Compares the new granules directly to standard adult tablets.
- Checks whether eating a high-fat meal changes how the medicine is absorbed.
- Open to healthy adults aged 18 and over.
- Involves clinic stays, routine health checks, and regular blood samples.
Who may be eligible?
This trial is open to healthy adult volunteers aged 18 and older. Because this is an early-stage study focused on how the human body absorbs the medicine, volunteers do not need to have a history of blood clots, heart disease, or any other specific health condition.
To take part, you should generally be in good physical health. People with active bleeding problems, liver or kidney issues, or those taking regular prescription medicines that could interfere with blood clotting are usually not able to join.
Women who are pregnant or breastfeeding will not be eligible to participate. Before anyone joins, the clinic team will run routine health checks, such as blood tests and heart tracings, to ensure taking part is safe for each person.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- I am aged 18 or older.
- I consider myself to be in good overall physical health.
- I do not have a history of serious bleeding or blood-clotting disorders.
- I am not currently pregnant or breastfeeding.
- I am willing to stay overnight at a clinical research facility and have blood tests taken.
What does participation involve?
Taking part involves staying at a specialist clinical research unit for short periods. During the study, you will receive single doses of asundexian at different times—once as a regular tablet on an empty stomach, once as granules on an empty stomach, and once as granules following a high-calorie breakfast. Nurses and doctors will carry out regular health checks, including measuring your blood pressure and taking blood samples across the day to track medicine levels. The total study duration is typically several weeks, which includes your initial screening visit, the clinic stays, and a final follow-up check to make sure you are feeling well.
Potential risks and benefits
Locations (1)
- —UnverifiedGermany
Common questions
Why are adults testing a medicine meant for children?
Testing new medicine versions in healthy adults first is a standard safety rule. It helps researchers understand how the body handles the medicine before involving children.
Is asundexian already available from a GP?
No, asundexian is still an experimental medicine undergoing clinical trials and is not yet approved for general prescription.
Will taking this medicine make me bleed easily?
Because it works by preventing blood clots, you might notice minor bruising or bleeding (such as when brushing your teeth), but medical staff will watch you carefully to keep you safe.
Why do I have to eat a high-fat breakfast?
Food can alter how quickly medicines move from your stomach into your blood. Testing after a heavy meal shows doctors if the medicine must be taken with or without food.
Are travel costs and time covered?
Healthy volunteer studies in the UK usually offer reimbursement for your time, inconvenience, and reasonable travel costs.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.